Large-scale testing (Phase 3)Study completedNCT01271712
What this trial is testing
Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)
Who this might be right for
Gastrointestinal Stromal Tumors
Bayer 199